Package | Dosage | Price | Price per Dose | |
---|---|---|---|---|
Dosage: 10mg | ||||
240 pill | 10mg | AUD575.65 | AUD2.40 | |
180 pill | 10mg | AUD434.07 | AUD2.41 | |
120 pill | 10mg | AUD292.48 | AUD2.44 | |
90 pill | 10mg | AUD231.81 | AUD2.57 | |
60 pill | 10mg | AUD161.79 | AUD2.69 | |
30 pill | 10mg | AUD87.11 | AUD2.88 | |
10 pill | 10mg | AUD32.66 | AUD3.30 | |
Dosage: 20mg | ||||
120 pill | 20mg | AUD533.64 | AUD4.45 | |
90 pill | 20mg | AUD407.62 | AUD4.53 | |
60 pill | 20mg | AUD287.82 | AUD4.81 | |
30 pill | 20mg | AUD157.13 | AUD5.23 | |
10 pill | 20mg | AUD57.55 | AUD5.77 |

Leflunomide Description
Introduction to Leflunomide
Leflunomide is an immunomodulatory medication commonly used in the treatment of autoimmune diseases, particularly rheumatoid arthritis. It belongs to a class of drugs known as disease-modifying antirheumatic drugs (DMARDs). By suppressing the immune system's abnormal response, leflunomide helps reduce inflammation, joint damage, and pain associated with joint diseases. Its effectiveness has made it a popular choice for patients seeking long-term management of rheumatoid conditions.
How Leflunomide Works
The primary mechanism of leflunomide involves inhibiting the enzyme dihydroorotate dehydrogenase. This enzyme is crucial for pyrimidine synthesis, which is necessary for the proliferation of activated lymphocytes. By blocking this pathway, leflunomide limits the growth and activity of immune cells that contribute to inflammation and tissue damage in autoimmune diseases. Consequently, patients experience reduced joint swelling, stiffness, and pain. The drug’s action is systemic, which helps in controlling the overall immune response rather than merely alleviating symptoms.
Benefits of Using Leflunomide
Many patients find leflunomide effective in managing their rheumatoid arthritis symptoms. One notable benefit is its ability to slow disease progression and prevent joint deformities over time. Additionally, it offers the convenience of once-daily dosing, which helps improve medication adherence. Unlike some other DMARDs, leflunomide can be used as monotherapy or combined with other treatments, depending on the severity of the condition. For many users, it provides significant relief and improves their overall quality of life.
Possible Side Effects
Like all medications, leflunomide can cause side effects. Some patients might experience gastrointestinal issues such as nausea, diarrhea, or abdominal discomfort. Elevated liver enzymes are also a concern, so regular liver function tests are recommended during treatment. Hair loss and mild skin rashes have been reported in some cases. More serious but less common side effects include blood cell count abnormalities, which may increase the risk of infections or bleeding. It is crucial to monitor health regularly and report any unusual symptoms to a healthcare provider promptly.
Precautions and Contraindications
Leflunomide should be used with caution in patients with pre-existing liver disease or significant liver enzyme elevations. Pregnant women are advised against using this medication, as it can be teratogenic and pose serious risks to fetal development. Women of childbearing age should use effective contraception during treatment and for some time after discontinuation. Patients with certain infections or immune deficiencies should discuss their condition with their doctor before starting leflunomide. Ensuring proper medical supervision helps mitigate risks and maximizes the benefits of therapy.
Conclusion
Leflunomide remains a valuable medication for managing autoimmune joint diseases. Its targeted mechanism helps control disease activity while aiming to preserve joint structure and function. However, careful monitoring and adherence to medical advice are essential to minimize side effects and optimize outcomes. Patients considering this treatment should have thorough discussions with their healthcare providers to understand the potential benefits and risks involved. With appropriate use, leflunomide can significantly improve the daily lives of individuals battling rheumatoid arthritis and related conditions.